The Society of Publishers in Asia (SOPA), a not-for-profit organization dedicated to championing editorial excellence and press freedom across the Asia-Pacific region, announced today that the SOPA ...
Rachael Kao (right), President of CTBC Financial Holding, joins the “CEO Keynote interview” at the Financial Times Global ...
Omdia's Cellular IoT Market Tracker 2021-2035 highlights the latest trends in the cellular IoT market, providing key analysis ...
Tecnotree is a 5G-ready digital Business Support System (BSS) provider with advanced AI/ML capabilities and multi-cloud ...
Four-time WNBA All-Star Sabrina Ionescu today becomes a new Global Brand Ambassador for Ant International, a leading global ...
Macron says 'main issue' is finding 'convergence' between US, European and Ukrainian positions Boomi™, the leader in ...
iFIT, a global leader in connected fitness, content, and equipment, and F45 Training, a leading global fitness community and ...
Account protection against deepfake attacks: Ant International’s AI-powered anti-deepfake measures have achieved a detection ...
Both studies provide new insights into how ropeginterferon alfa-2b may help people living with these chronic blood cancers. Martin Steinhart, CEO of AOP Health, concludes: “AOP Health was founded to ...
CoMotion GLOBAL 2025 features a two-stage program, dedicated Mobility Labs, the inaugural CoMotion Urban Visionary Distinction, and the launch of Mayors in Motion – a global network for city leaders ...
PUMA has opened the doors to its largest-ever European flagship store on Oxford Street in London, which will bring the best ...
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 2026
Our research reflects a relentless focus on improving patient outcomes through innovation in neurotoxin science,” said Dr. Stefan Albrecht, Chief Scientific and Medical Officer at Merz Therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback